TERT structural rearrangements in metastatic pheochromocytomas

Trisha Dwight; Aidan Flynn; Kaushalya Amarasinghe; Diana E Benn; Richard Lupat; Jason Li; Daniel L Cameron; Annette Hogg; Shiva Balachander; Ida LM Candiloro; Stephen Q Wong; Bruce G Robinson; Anthony T Papenfuss; Anthony J Gill; Alexander Dobrovic; Rodney J Hicks; Roderick J Clifton-Bligh; Richard W Tothill

Journal article

TERT structural rearrangements in metastatic pheochromocytomas

Trisha Dwight, Aidan Flynn, Kaushalya Amarasinghe, Diana E Benn, Richard Lupat, Jason Li, Daniel L Cameron, Annette Hogg, Shiva Balachander, Ida LM Candiloro, Stephen Q Wong, Bruce G Robinson, Anthony T Papenfuss, Anthony J Gill, Alexander Dobrovic, Rodney J Hicks, Roderick J Clifton-Bligh, Richard W Tothill

Endocrine-Related Cancer | BIOSCIENTIFICA LTD | Published : 2018

DOI: 10.1530/ERC-17-0306

University of Melbourne Researchers

Stephen Wong Author The Sir Peter MacCallum Department of Oncology

Richard Tothill Author Clinical Pathology

Rodney Hicks Author Medicine - St Vincent's Hospital

Kaushalya Amarasinghe Author The Sir Peter MacCallum Department of Oncology

Tony Papenfuss Author Medical Biology (W.E.H.I.)

Related Projects (2)

Hereditary Endocrine Cancer: A Model Based On Phaeochromocytoma – Paraganglioma Syndromes

Phaeochromocytomas and paragangliomas are tumours remarkable for their very high heritability. They have a high burden of disease themselves..

Oncogenic Signaling And Cancer Therapy

Central to improving the management of patients with cancer is an understanding of the molecular drivers of cancer. Based on our fundamental..

Grants

Awarded by National Health and Medical Research Council

Funding Acknowledgements

This work was supported by grants from the National Health and Medical Research Council (APP1108032 to R.C.B., R.W.T., T.D., D.E.B., A.J.G and APP1053792 to RJH), Hillcrest Foundation (Perpetual Trustees; T.D., D.E.B., B.G.R.), Pheo Para Alliance (T.D., R.C.B., D.E.B., B.G.R.) and the National Breast Cancer Foundation to A.D. The Olivia Newton-John Cancer Research Institute acknowledges the support of the Victorian Government Operational Infrastructure Support Program.